Business News, In Brief
Pfizer Lays Out Primary Care Business Development Opportunities
You may also be interested in...
MUMBAI - In August, when leading Indian drug maker Dr. Reddy's Labs launched Cresp, a biosimilar brand of Amgen's darbepoetin alfa Aranesp, G.V.Prasad, Reddy's chief executive officer exulted at a media briefing that his company may well be on course to becoming the largest biologics player in the world in a few years, next only to Swiss giant Roche
Teva will launch its generic only if an appeals court finds the Temodar patent is unenforceable; otherwise it can do so six months before the patent expires.
FDA-delayed vernakalant for atrial fibrillation nets handsome pact, as more-lucrative oral form awaits Phase III trials.